Related Articles
IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance
Excessive activation of IL‑33/ST2 in cancer‑associated fibroblasts promotes invasion and metastasis in ovarian cancer
IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
Role of the IL‑33/ST2 receptor axis in ovarian cancer progression (Review)
SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer